615-48-5 Usage
Uses
Used in Dye and Pigment Manufacturing:
5-CHLORO-2-MERCAPTOANILINE HYDROCHLORIDE is used as a key intermediate in the production of azo dyes, which are extensively employed in the textile industry for their colorfast properties and wide range of hues.
Used in Pharmaceutical Synthesis:
In the pharmaceutical industry, 5-CHLORO-2-MERCAPTOANILINE HYDROCHLORIDE is used as a chemical intermediate for the synthesis of various medicinal compounds, contributing to the development of new drugs.
Used in Agrochemical Production:
5-CHLORO-2-MERCAPTOANILINE HYDROCHLORIDE also serves as an intermediate in the synthesis of agrochemicals, playing a role in the creation of products that protect crops and enhance agricultural yields.
Used in Organic Synthesis:
5-CHLORO-2-MERCAPTOANILINE HYDROCHLORIDE is utilized in organic synthesis for the development of new chemical entities, potentially leading to advancements in various chemical and material sciences.
Used in Material Development:
5-CHLORO-2-MERCAPTOANILINE HYDROCHLORIDE has potential applications in the research and development of new materials, where its unique properties may contribute to innovative solutions in material science.
Check Digit Verification of cas no
The CAS Registry Mumber 615-48-5 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 6,1 and 5 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 615-48:
(5*6)+(4*1)+(3*5)+(2*4)+(1*8)=65
65 % 10 = 5
So 615-48-5 is a valid CAS Registry Number.
InChI:InChI=1/C6H6ClNS.ClH/c7-4-1-2-6(9)5(8)3-4;/h1-3,9H,8H2;1H
615-48-5Relevant articles and documents
Therapeutic modulation of PPARgamma activity
-
Page/Page column 55, (2010/02/14)
Modulators of PPARγ activity are used in methods of treating and/or preventing conditions such as osteoporosis, Alzheimer's disease, psoriasis and acne, and cancer.
Compounds for the modulation of PPARgamma activity
-
, (2008/06/13)
Modulators of PPARγ activity are provided which are useful in pharmaceutical compositions and methods for the treatment of conditions such as type II diabetes and obesity.